Avignon, 11 June 2012 - NATUREX, world leader in specialty plant-based ingredients, is informing its shareholders of the decision of the Board of Directors meeting on 8 June 2012, held after the General Meeting, about its governance and the operational management of the Group.
By decision of the shareholders of NATUREX gathered at the Joint Shareholders' Meeting on 8 June 2012, Mr Jacques DIKANSKY and Mr Thierry LAMBERT were re-appointed in their mandate as directors of the Company, for a term of 6 years, i.e. until the Shareholders' Meeting called to vote on the financial statements for the period ending 31 December 2017. The Board of Directors is moreover comprised of Paul and Olivier LIPPENS, independent directors and directors of FINASUCRE, Stéphane DUCROUX, Vice-President of NATUREX Inc., and Jacqueline DIKANSKY.
The Board of Directors of NATUREX confirmed the re-election of Mr Jacques DIKANSKY as Chairman for the term of his mandate as director. However, as the current state of his health does not allow him to fulfil this function, the effective chairing of the Board of Directors is delegated to Mr Thierry LAMBERT, in his capacity as Vice-President; Mr LAMBERT is also appointed to the functions of CEO of NATUREX.
The Board of Directors stipulated that if the health of Mr Jacques DIKANSKY were to allow him, he will again be entrusted with the General Management of the Company, Mr Thierry LAMBERT would then return to his function as Deputy CEO.
From an operational standpoint, a Management Committee has been set up, bringing together experienced managing executives in charge of the Group's main operational functions, and who for the most part have been working within NATUREX for many years.
You can receive all of NATUREX's financial information free of charge by signing up on: www.naturex.com
NATUREX is the world leader in specialty plant-based ingredients.
The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care -, produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetics industries.
NATUREX's head office is based in Avignon. Naturex employs over 1,200 people and has high-performance industrial resources across its 16 industrial sites in Europe (France, Italy, Spain, United Kingdom, Switzerland and Poland), in Morocco, the United States, Brazil, Australia and India. The company draws on its worldwide sales presence through a fully dedicated sales network in 21 countries (France, Italy, Spain, Morocco, United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, United States, Canada, Brazil, Mexico, India).
NATUREX enjoys the highly favourable underlying trend linked to increasing demand for natural-origin products and provides manufacturers with personalised solutions in order to meet the expectations of the end consumers. The force of the Group resides in its positioning on specific products that form market niches, thanks to a strong sourcing capacity and support for Research and Development.
Naturex has been listed since October 1996 on NYSE Euronext in Paris, compartment B
|Number of shares comprising the capital: 7,711,076
6,953,768 ordinary shares (ISIN FR0000054694)
757,308 preferred shares (ISIN FR0010833251)
Naturex is part of the CAC Small and Gaïa Indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex has set up a sponsored level I American Depositary Receipt (ADR) programme. Naturex's ADRs are traded over the counter in the United States under the symbol NTUXY.
MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
Vice-President and CEO
Tel.: +33 (0)4 90 23 96 89
Tel.: +33 (0)4 90 23 78 28
|Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-28251-2012.06.11-information-about-the-governance-an-the-operational-management-of-naturex.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|NATUREX||Euronext Paris||85.48 (c)||0.32%||3 861|